The demand for advanced Neurodegenerative Disease Devices is being significantly driven by the growing burden of ...
Medtronic has been hiking its dividend for nearly 50 consecutive years. It's spinning off its diabetes division to focus on faster-growing businesses. Its strategy makes sense -- and its valuation is ...
Neuroscience Portfolio revenue of $2.558 billion, an increase of 4.1% reported and 2.5% organic, with a mid-single digit increase in Neuromodulation, a mid-single digit increase in Cranial & Spinal ...
Shares drop 2.6% despite beating quarterly expectations Company expects $300 million hit from tariffs in fiscal 2027 CEO says Danaher-Masimo deal will not change patient-monitoring market long term ...
Four years ago, CathWorks and Medtronic plc, one of the world’s largest medical device makers, struck up a co-promotion agreement with the option for Medtronic to buy the Irvine-based cardiac-focused ...
Medical device company Applied Medical has been awarded $381,705,005 in damages after a federal jury in California found Medtronic liable for violations of federal and state antitrust laws. In ...
Applied Medical has been awarded $382 million in damages from Medtronic after a U.S. District Court jury in California unanimously found the medtech giant liable for suppressing competition of ...
Three University of Colorado campuses, including CU Boulder, announced a partnership on Thursday with the global healthcare technology company Medtronic aimed at accelerating the development of new ...
Medtronic has plans to purchase $90 million worth of shares in Anteris Technologies Global, a company that specializes in the development of transcatheter aortic valve replacement devices. Medtronic’s ...
Jan 12 (Reuters) - Medtronic (MDT.N), opens new tab has "significant firepower" to pursue acquisitions as the medical device maker evaluates opportunities to expand its portfolio, executives said at a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results